Logo image of BALY

BALLY'S CORP-ROLLOVER SHS (BALY) Stock Fundamental Analysis

NYSE:BALY - New York Stock Exchange, Inc. - US05875B1061 - Common Stock - Currency: USD

16.01  +0.31 (+1.97%)

Fundamental Rating

2

Taking everything into account, BALY scores 2 out of 10 in our fundamental rating. BALY was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BALY have multiple concerns. While showing a medium growth rate, BALY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
In the past year BALY had a positive cash flow from operations.
In the past 5 years BALY reported 4 times negative net income.
In the past 5 years BALY always reported a positive cash flow from operatings.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

BALY's Return On Assets of -11.87% is on the low side compared to the rest of the industry. BALY is outperformed by 91.60% of its industry peers.
BALY has a Return On Equity of -325.75%. This is in the lower half of the industry: BALY underperforms 68.70% of its industry peers.
Industry RankSector Rank
ROA -11.87%
ROE -325.75%
ROIC N/A
ROA(3y)-3.75%
ROA(5y)-1.23%
ROE(3y)-29.81%
ROE(5y)-13.01%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

BALY's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 54.38%, BALY is in the better half of the industry, outperforming 65.65% of the companies in the same industry.
In the last couple of years the Gross Margin of BALY has declined.
BALY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.38%
OM growth 3Y-4.68%
OM growth 5Y-32.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.4%
GM growth 5Y-4.87%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

BALY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BALY has less shares outstanding
BALY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BALY has an improved debt to assets ratio.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

BALY has an Altman-Z score of 0.19. This is a bad value and indicates that BALY is not financially healthy and even has some risk of bankruptcy.
BALY has a Altman-Z score of 0.19. This is amonst the worse of the industry: BALY underperforms 80.92% of its industry peers.
BALY has a Debt/Equity ratio of 15.64. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 15.64, BALY is doing worse than 67.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 15.64
Debt/FCF N/A
Altman-Z 0.19
ROIC/WACCN/A
WACC8.35%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

BALY has a Current Ratio of 0.56. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
BALY's Current ratio of 0.56 is on the low side compared to the rest of the industry. BALY is outperformed by 71.76% of its industry peers.
BALY has a Quick Ratio of 0.56. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
BALY has a worse Quick ratio (0.54) than 69.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.54
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BALY have decreased strongly by -118.96% in the last year.
Looking at the last year, BALY shows a small growth in Revenue. The Revenue has grown by 2.80% in the last year.
The Revenue has been growing by 41.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-118.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-343.48%
Revenue 1Y (TTM)2.8%
Revenue growth 3Y87.29%
Revenue growth 5Y41.13%
Sales Q2Q%-0.4%

3.2 Future

BALY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.05% yearly.
Based on estimates for the next years, BALY will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-44.16%
EPS Next 2Y29.59%
EPS Next 3Y17.57%
EPS Next 5Y16.05%
Revenue Next Year0.36%
Revenue Next 2Y-0.34%
Revenue Next 3Y1.48%
Revenue Next 5Y0.49%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

BALY's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.18
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

BALY's earnings are expected to grow with 17.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.59%
EPS Next 3Y17.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BALY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLY'S CORP-ROLLOVER SHS

NYSE:BALY (2/12/2025, 8:04:00 PM)

16.01

+0.31 (+1.97%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners71.17%
Inst Owner Change-62.37%
Ins Owners15.22%
Ins Owner Change0.32%
Market Cap1.30B
Analysts51.67
Price Target17.57 (9.74%)
Short Float %4.67%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1375.15%
Min EPS beat(2)-2765.33%
Max EPS beat(2)15.03%
EPS beat(4)1
Avg EPS beat(4)-857.77%
Min EPS beat(4)-2765.33%
Max EPS beat(4)15.03%
EPS beat(8)1
Avg EPS beat(8)-1080.91%
EPS beat(12)3
Avg EPS beat(12)-725.36%
EPS beat(16)4
Avg EPS beat(16)-511.03%
Revenue beat(2)0
Avg Revenue beat(2)-5.28%
Min Revenue beat(2)-5.87%
Max Revenue beat(2)-4.69%
Revenue beat(4)0
Avg Revenue beat(4)-4.41%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-3.26%
Revenue beat(8)0
Avg Revenue beat(8)-3.21%
Revenue beat(12)0
Avg Revenue beat(12)-4.22%
Revenue beat(16)2
Avg Revenue beat(16)-2.99%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-31.94%
EPS NQ rev (3m)-30.11%
EPS NY rev (1m)-0.34%
EPS NY rev (3m)-30.19%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-2.04%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF 8.89
P/B 5.58
P/tB N/A
EV/EBITDA 12.18
EPS(TTM)-12.24
EYN/A
EPS(NY)-2.39
Fwd EYN/A
FCF(TTM)-2.91
FCFYN/A
OCF(TTM)1.8
OCFY11.25%
SpS30.51
BVpS2.87
TBVpS-43.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.87%
ROE -325.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.38%
FCFM N/A
ROA(3y)-3.75%
ROA(5y)-1.23%
ROE(3y)-29.81%
ROE(5y)-13.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.63%
ROCE(5y)4.48%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.68%
OM growth 5Y-32.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.4%
GM growth 5Y-4.87%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 15.64
Debt/FCF N/A
Debt/EBITDA 9.35
Cap/Depr 88.03%
Cap/Sales 15.45%
Interest Coverage N/A
Cash Conversion 37.5%
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.54
Altman-Z 0.19
F-Score4
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)141.25%
Cap/Depr(5y)110.25%
Cap/Sales(3y)18.4%
Cap/Sales(5y)12.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-343.48%
EPS Next Y-44.16%
EPS Next 2Y29.59%
EPS Next 3Y17.57%
EPS Next 5Y16.05%
Revenue 1Y (TTM)2.8%
Revenue growth 3Y87.29%
Revenue growth 5Y41.13%
Sales Q2Q%-0.4%
Revenue Next Year0.36%
Revenue Next 2Y-0.34%
Revenue Next 3Y1.48%
Revenue Next 5Y0.49%
EBIT growth 1Y-121.65%
EBIT growth 3Y78.53%
EBIT growth 5Y-5.29%
EBIT Next Year39.02%
EBIT Next 3Y16.62%
EBIT Next 5Y10.7%
FCF growth 1Y-87.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.29%
OCF growth 3Y112.44%
OCF growth 5Y11.35%